Pagani FD - Search Results

1

Neill S, Engoren M, Kouatli Y, Shields TA, Jewell E, Pagani FD. Neill S, et al. Among authors: pagani fd. J Cardiothorac Vasc Anesth. 2015 Apr;29(2):297-302. doi: 10.1053/j.jvca.2014.07.002. Epub 2014 Dec 6. J Cardiothorac Vasc Anesth. 2015. PMID: 25488077

2

Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization.

Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T, Moscucci M, Deeb GM, Bolling S, Monaghan H, Aaronson KD. Pagani FD, et al. Circulation. 1999 Nov 9;100(19 Suppl):II206-10. doi: 10.1161/01.cir.100.suppl_2.ii-206. Circulation. 1999. PMID: 10567305

3

The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device.

Pagani FD, Aaronson KD, Swaniker F, Bartlett RH. Pagani FD, et al. Ann Thorac Surg. 2001 Mar;71(3 Suppl):S77-81; discussion S82-5. doi: 10.1016/s0003-4975(00)02620-5. Ann Thorac Surg. 2001. PMID: 11265871

4

Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival.

Pagani FD, Dyke DB, Wright S, Cody R, Aaronson KD. Pagani FD, et al. J Heart Lung Transplant. 2001 Jun;20(6):646-53. doi: 10.1016/s1053-2498(01)00232-7. J Heart Lung Transplant. 2001. PMID: 11404170

5

Left ventricular assist device therapy improves utilization of donor hearts.

Aaronson KD, Eppinger MJ, Dyke DB, Wright S, Pagani FD. Aaronson KD, et al. Among authors: pagani fd. J Am Coll Cardiol. 2002 Apr 17;39(8):1247-54. doi: 10.1016/s0735-1097(02)01751-5. J Am Coll Cardiol. 2002. PMID: 11955839 Free article.

6

Patient selection for left ventricular assist device therapy.

Aaronson KD, Patel H, Pagani FD. Aaronson KD, et al. Among authors: pagani fd. Ann Thorac Surg. 2003 Jun;75(6 Suppl):S29-35. doi: 10.1016/s0003-4975(03)00461-2. Ann Thorac Surg. 2003. PMID: 12820732 Review.

7

Roseomonas infection associated with a left ventricular assist device.

Singal A, Malani PN, Day LJ, Pagani FD, Clark NM. Singal A, et al. Among authors: pagani fd. Infect Control Hosp Epidemiol. 2003 Dec;24(12):963-5. doi: 10.1086/502168. Infect Control Hosp Epidemiol. 2003. PMID: 14700415

8

Improved mechanical reliability of the HeartMate XVE left ventricular assist system.

Pagani FD, Long JW, Dembitsky WP, Joyce LD, Miller LW. Pagani FD, et al. Ann Thorac Surg. 2006 Oct;82(4):1413-8. doi: 10.1016/j.athoracsur.2006.04.057. Ann Thorac Surg. 2006. PMID: 16996944

9

Identification of device malfunction in patients supported with the HeartMate XVE left ventricular assist system.

Haft JW, Suzuki Y, Aaronson KD, Dyke DB, Wright S, Poirier VL, Pagani FD. Haft JW, et al. Among authors: pagani fd. ASAIO J. 2007 May-Jun;53(3):298-303. doi: 10.1097/MAT.0b013e318033a6b0. ASAIO J. 2007. PMID: 17515718

10

Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices.

Haft J, Armstrong W, Dyke DB, Aaronson KD, Koelling TM, Farrar DJ, Pagani FD. Haft J, et al. Among authors: pagani fd. Circulation. 2007 Sep 11;116(11 Suppl):I8-15. doi: 10.1161/CIRCULATIONAHA.106.677898. Circulation. 2007. PMID: 17846330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters